Bilcare Ltd

[bilcareltd-blog]

View product list... https://goo.gl/rhJjdA

[bilcareltd-blog]

Bilcare Research - Welcomes you to the new world of Innovative Pharma Packaging Solutions at CPhI India

Mumbai, November 9, 2016:  Bilcare Research - global pharma packaging solution provider to 1200 customers across 120 countries will be showcasing array of packaging innovations at CPhI India (21-23 November, 2016) at BEC, Goregaon, Mumbai.

Bilcare has over 200 filed patents in pharma packaging solutions and technology, including Brandpak™ and Optima™ proprietary solutions for brand growth and optimal packaging, besides wide choice of innovative solutions. 

In addition to pharma packaging innovations, Bilcare also caters to clinical supplies and integrated breakthrough nonClonable, mobile enabled technology for resolving three concerns, namely: Authentication, Track & Trace and Compliance.

Company’s Chairman & Managing Director, Mr. Mohan Bhandari will be addressing industry leaders at CPhI Exhibitor Showcase on 22.11.16 during afternoon session (3-3.45pm). 

………………………………………………………………………………………………………………………………………………………………………

To learn more logon to https://www.facebook.com/Bilcare.Ltd

[bilcareltd-blog]

Bilcare Research Segregates Pharma-Related Production Operations

Bilcare Research Inc., a division of one of the world’s largest manufacturers of blister packaging solutions, has begun segregating pharma-related production operations from those servicing other industries at its Wilmington, DE facility. The decision showcases Bilcare‘s commitment to the pharmaceutical sector amid growing customer demand and heightened quality control expectations. Part of the global Pharmaceutical Packaging Innovation (PPI) Business Unit of Bilcare Research AG,  Bilcare Research offers a variety of mono and barrier blister films to the pharmaceutical packaging industry.  In addition to manufacturing pharmaceutical blister films, the company also produces products for other business units of the company.

With growing customer demand and a steadily increasing market share in the pharmaceutical films sector, Bilcare’s effort to separate its PPI production and storage area from areas servicing other businesses has the purpose of clearly differentiating its production process along industry-specific lines.  The result is the ability to service all sectors more efficiently.

Distributional

“We are dedicated to our pharmaceutical customers and this is just one more example of how,” said Kevin Stevens, President and Managing Director of Bilcare Research Inc. “Our strategy is to exceed our customers’ expectations in the quality of Bilcare’s products; the new plant layout shows our commitment and investment to that end. Packaging pharmaceutical products in an ideal fashion calls for a dedicated, siloed production environment throughout the supply chain, and we aim to set the bar high toward that goal.”

[bilcareltd-blog]

Dr. Abhigyan Upadhyay, COO, Bilcare GCS receiving ABP News Healthcare Award for best Clinical Trial Services

Dr. Abhigyan Upadhyay, COO, Bilcare GCS receiving ABP News Healthcare award

Dr. Abhigyan Upadhyay, COO, Bilcare GCS with ABP News Healthcare award

[bilcareltd-blog]

Bilcare Research Address @ The 4th Speciality Films and Flexible Packaging Global Conference

Anti - counterfeit & High Barrier for Pharma Applications @ 4th SPECIALITY FILMS & FLEXIBLE PACKAGING 15 -16 Sep 2015, Hotel Grand Hyatt, Mumbai, India GLOBAL …

[bilcareltd-blog]

Vision and Values of Bilcare  Research

Vision Transforming Health Outcomes - Touching Lives Bilcare is a unique organization with a strong research foundation and unending quest for global leadership in the pharmaceutical and healthcare service space. An organization of passionate professionals who go that extra mile to share excellence and spread joy.

Values

Speed:Proactive and swift action is our mantra.

Innovation:Our continual commitment at all levels is to seek better ways of listening, thinking and doing - making our offerings meaningful and impactful.

Happiness:We are motivated by our customer's success and happiness of our stakeholders.

[bilcareltd-blog]

Bilcare 5Cs adaptation

Bilcare R&D is adapted to address the difficulties of the 5 Cs viz., Compliance, Counterfeiting, Communication, Convenience and Child Resistant. We cooperate with pharmaceutical majors to guarantee experimental streamlining, better timeframe of realistic usability, expanded strength of items, simplicity of dissemination and brand assurance.

Our R&D center is reflected in our quest for creating protected advancements. The engaged activity over all business exercises has brought about our organization petitioning for Patents, Trademarks and Registered packaging designs recorded in different jurisdictions around the world.

All Bilcare plants and R&D focuses are FDA/DEA enrolled, controlled and are in ordered regions. Our point is to be an one-stop incorporated administration supplier that works nearly with driving pharmaceutical organizations - over the worth chain, from 'drug discovery to market to track & trace of sales' .